Bruno LINA, President of IDCluster, signed the France 2030 aid contract with BPIFrance, with the support of the General Secretariat for Investment and the Health Innovation Agency.

Following its “Bioclusters France 2030” label in May 2023, Bruno LINA, President of IDCluster, and Bpifrance signed the France 2030 aid agreement on March 30, 2025, with the support of the General Secretariat for Investment and the Health Innovation Agency.

This contract provides for the financing of IDCluster by the French State via BpiFrance from 2025 to 2030 for a maximum amount of €4,259,000, on an equal footing with the three founding industrial companies (Sanofi, bioMérieux, Ceva Santé Animale) and the members of IDCluster.

This funding, starting in May 2025, is dedicated to operating expenses, communication, and skills/expertise mobilized to accelerate R&D projects and technology platforms, in line with IDCluster’s mission to accelerate their market launch and use.

In return of this France 2030 funding, IDCluster’s leaders have committed in particular to:

• Demonstrating the biocluster’s openness to any R&D project that meets the eligibility criteria for the R&D project and technology platform acceleration program
• Demonstrate its ability to drive the French MIE and AMR ecosystem in order to develop responses to pandemic threats and their national and European visibility
• Accelerate at least 12 R&D projects before April 2030